{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:20:57Z","timestamp":1769134857200,"version":"3.49.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":661,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"DOI":"10.1164\/rccm.202312-2338ed","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T10:06:16Z","timestamp":1706781976000},"page":"777-778","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":2,"title":["Lessons Are Still Being Learned about Intrapulmonary Antibiotic Concentrations"],"prefix":"10.1093","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-7346","authenticated-orcid":false,"given":"Keith A.","family":"Rodvold","sequence":"first","affiliation":[{"name":"Colleges of Pharmacy and Medicine, University of Illinois Chicago, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew F.","family":"Shorr","sequence":"additional","affiliation":[{"name":"Pulmonary and Critical Care Medicine, Medstar Washington Hospital Center, Washington, District of Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"2026012204273027800_bib1","doi-asserted-by":"crossref","first-page":"e02309","DOI":"10.1128\/AAC.02309-18","article-title":"Considerations for dose selection and clinical pharmacokinetics\/pharmacodynamics for the development of antibacterial agents","volume":"63","author":"Rizk","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"2026012204273027800_bib2","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1086\/653057","article-title":"Pharmacokinetic-pharmacodynamic considerations in the design of hospital-acquired or ventilator-associated bacterial pneumonia studies: look before you leap!","volume":"51","author":"Ambrose","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026012204273027800_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.coph.2017.09.019","article-title":"Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung","volume":"36","author":"Rodvold","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"2026012204273027800_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40262-021-01061-7","article-title":"Penetration of antimicrobial agents into pulmonary epithelial lining fluid: an update","volume":"61","author":"Drwiega","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"2026012204273027800_bib5","doi-asserted-by":"crossref","first-page":"E600","DOI":"10.1208\/aapsj070362","article-title":"Lung microdialysis\u2014a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)","volume":"7","author":"Zeitlinger","year":"2005","journal-title":"AAPS J"},{"key":"2026012204273027800_bib6","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/microorganisms9061154","article-title":"Nebulized colistin in ventilator-associated pneumonia and tracheobronchitis: historical background, pharmacokinetics, and perspectives","volume":"9","author":"Zhu","year":"2021","journal-title":"Microorganisms"},{"key":"2026012204273027800_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1378\/chest.11-3325","article-title":"Antibiotics in the critically ill: the bug, drug, host triad","volume":"142","author":"Shorr","year":"2012","journal-title":"Chest"},{"key":"2026012204273027800_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/clpt.2014.131","article-title":"Pulmonary penetration of piperacillin and tazobactam in critically ill patients","volume":"96","author":"Felton","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"2026012204273027800_bib9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1164\/rccm.202306-0974OC","article-title":"Antimicrobial drug penetration is enhanced by lung tissue inflammation and injury","volume":"209","author":"Geilen","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204273027800_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/11594090-000000000-00000","article-title":"Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents","volume":"50","author":"Rodvold","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"2026012204273027800_bib11","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1128\/AAC.00144-09","article-title":"Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole","volume":"53","author":"Rodvold","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012204273027800_bib12","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/jac\/dkab280","article-title":"Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia","volume":"76","author":"Katsube","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"2026012204273027800_bib13","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/jac\/dkx541","article-title":"Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers","volume":"73","author":"Felton","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026012204273027800_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40560-020-00510-y","article-title":"Corticosteroid treatment for early acute respiratory distress syndrome: a systematic review and meta-analysis of randomized trials","volume":"8","author":"Hirano","year":"2020","journal-title":"J Intensive Care"},{"key":"2026012204273027800_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/209\/7\/777\/66426411\/ajrccm_209_7_777.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/209\/7\/777\/66426411\/ajrccm_209_7_777.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:27:42Z","timestamp":1769074062000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/209\/7\/777\/8426993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":15,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4,1]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202312-2338ed","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"2024-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}